VHA Selects Clinical Xpert from Thomson Reuters as its Preferred Solution for Mobile Clinical Improvement Systems
ANN ARBOR, Mich., March 2 /PRNewswire/ -- The Healthcare business of Thomson Reuters has been selected by VHA Inc., the national healthcare alliance, as its preferred vendor for mobile clinical quality improvement solutions.
With this preferred vendor designation, Thomson Reuters is autho...
Thomson Reuters Installs Clinical Xpert at Catholic Healthcare West for HIS Downtime Solution
ANN ARBOR, Mich., Jan. 28 /PRNewswire/ -- Thomson Reuters announced today
that Catholic Healthcare West (CHW), the eighth largest hospital system in the
United States, has implemented Clinical Xpert(TM) as its downtime solution
when access to the hospital information system (HIS) and electroni...
Clinical Xpert Navigator From Thomson Reuters Is Named Best Mobile Data System in the KLAS Awards - for Seventh Consecutive Year
ANN ARBOR, Mich., Jan. 7 /PRNewswire/ -- The Healthcare business of
Thomson Reuters announced today that its Clinical Xpert(TM) Navigator has been
named the Category Leader for Mobile Data Systems in the latest "Top 20 Best
in KLAS Awards: Software & Professional Services" report.
The Peer Group Launches Xpert Xchange(SM), an Innovation in Medical Peer Influence Programs
EDISON, N.J., July 7 /PRNewswire/ -- The Peer Group, a leading provider
of peer-to-peer medical forums for the bio-pharmaceutical industry, and an
Informed Medical Communications (IMC) company, today announced the launch
Xchange is the newest innovation in moderated...
Thomson Healthcare's Clinical Xpert Navigator Tops KLAS Annual Performance Ranking in Mobile Data Systems for Sixth Consecutive Year
STAMFORD, Conn., Feb. 12 /PRNewswire/ -- Thomson Healthcare, the
leading provider of integrated decision support solutions that assist
healthcare organizations in their efforts to improve clinical and business
performance, announced that its Clinical Xpert
Navigator solution has been
Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
Broadlane Members Include Hospital Systems Such as Tenet and Kaiser
SUNNYVALE, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced it signed a group purchasing contract with Broadlane,
a leading supply chain services company serving more than 20,000 acute care
Weight-Loss Medication Evaluated By Nutrition Expert
A 60 mg low-dose version of the prescription weight-loss medication orlistat (marketed by GlaxoSmithKline as Xenical? 120 mg) was found to be safe, effective and tolerable in overweight individuals,// according to new data presented today at the 2005 Annual Meeting of NAASO, The Obesity Society in ...
Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
...auses Clostridium difficile infection (CDI). The xpert
C. difficile test is the first test for CDI to d...of rapid and accurate HAI tests on the market. The xpert
C. difficile test establishes new levels of spee...urate diagnostic tests. Our novel approach for the xpert
C. difficile test, as measured against the true ...
Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)
...y announced test for Mycobacterium tuberculosis , xpert
BCR-ABL Monitor uses nested PCR, a critical amplif...ed as often as four times a year.
BCR-ABL Monitor test is a powerful tool for monito...ho may be at risk for relapse."
The improved xpert
BCR-ABL Monitor test highlights the broad market a...
Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
...as issued Cepheid a medical device license for its xpert
HemosIL FII & FV test. The test detects Factor...ia, an increased risk of blood clots (thrombosis). xpert
HemosIL FII & FV delivers results in just over... (IL), the exclusive worldwide distributor for the xpert
HemosIL FII & FV test.
"Given the comple...
Xpert in Medical Technology
Xpert in Biological Technology
Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
License Enables Access to Canadian HAI Market; Market Expenditures for MRSA Surveillance Expected to Reach $80 Million by 2012
SUNNYVALE, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced that Health Canada has issued a medical device
license for the Xper...
New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery
... test to fully meet current CDC criteria for rapid intrapartum GBS testing. xpert
GBS is also the only PCR-based antepartum and intrapartum GBS test to recei...rses to run the test near-patient -- 24 hours a day, 365 days a year.
GBS runs on Cepheid's GeneXpert(R) System, the world's leading on-demand mo...
Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
...ycobacterium tuberculosis - a product that, in my opinion, is one of the most important diagnostic developments to have occurred in many years."
MTB/RIF not only detects the presence of TB organism directly from sputum in less than two hours, but also identifies whether the strain is resistant ...
Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
...cs and this capability is on full display with the xpert
MTB/RIF test. Clinicians will now be able to obtai...trains of tuberculosis and the availability of the xpert
MTB/RIF test should be a breakthrough technologica...ailable as a CE IVD Mark product next month."
MTB/RIF not only detects the presence of TB, but a...
Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
for the fourth quarter of 2008, which compares to xpert
MRSA test revenue of
approximately $5 million repo...in the fourth quarter of 2007. For the full
MRSA test revenue is expected to be approximately ...rest in our GeneXpert system and expanding menu of xpert
continues to grow, ongoing economic turbulen...
Dorset County Hospital Enhances MRSA Surveillance Programme Through Rapid Patient Screening
...ctor of Nursing and Infection Prevention and Control,
says, "We are always looking for new ways to further prevent infection and
improve patient care. xpert
MRSA rapid screening technology will vastly
reduce the risks to patients admitted to Dorset County Hospital and I hope
will provide further reassuranc...
Cepheid Reports Third Quarter Revenue of $44.9 Million
...otal revenue to be in the range of $174 to $176 million, of which product sales are expected to be in the range of $164 to $166 million. o xpert
MRSA test sales are expected to be in the range of $49 to $51 million. -- Net loss for 2008 is expected to be in the range of $22.5 to ...
Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
... doctors at the hospital to identify
MRSA carriers in under an hour. To validate the 100 percent accuracy rate
of the on-demand results obtained using xpert
MRSA, all results so far have
been verified with a traditional culture-based test, which takes up to
three days for results. The hospital has already ...
Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA
... (SA), (typically Methicillin-sensitive) in SSTIs. xpert
runs on Cepheid's GeneXpert(R) System...s).
Cleared by the FDA for marketing last month, xpert
MRSA/SA SSTI is the
first molecular SSTI diagnosti...ls throughout the U.S.
"The value proposition of xpert
MRSA/SA SSTI is resonating well with
Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
...sitive cocci -- in less than one hour.
MRSA/SA BC test processes positive blood culture
"With the addition of our xpert
MRSA/SA Blood Culture diagnostic test,
Cepheid is ...atients are five times as likely to be
MRSA/SA BC delivers on-demand test results to assi...